Live Oak Investment Partners acquired a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 13,763 shares of the company’s stock, valued at approximately $1,769,000. Merck KGaA accounts for 1.0% of Live Oak Investment Partners’ portfolio, making the stock its 26th biggest holding.
Other hedge funds and other institutional investors have also modified their holdings of the company. Frazier Financial Advisors LLC bought a new position in Merck KGaA during the second quarter worth $25,000. Addison Advisors LLC acquired a new position in Merck KGaA during the 2nd quarter valued at $90,000. Comprehensive Financial Planning Inc. PA bought a new stake in Merck KGaA in the 2nd quarter valued at $134,000. Stevens Capital Partners bought a new stake in Merck KGaA in the 2nd quarter valued at $220,000. Finally, United Bank acquired a new stake in Merck KGaA in the 2nd quarter worth $248,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Performance
OTCMKTS:MKGAF opened at $167.38 on Thursday. The firm’s 50-day moving average is $162.50 and its 200-day moving average is $148.28. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The company has a market cap of $21.63 billion, a price-to-earnings ratio of 25.55 and a beta of 0.96.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
